Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

Nathan Fowler; Brad S. Kahl; Peter Lee; Jeffrey V. Matous; Amanda F. Cashen; Samuel A. Jacobs; Jeffrey Letzer; Bipinkumar Amin; Michael E. Williams; Sonali Smith; Alfred Saleh; Peter Rosen; Hongliang Shi; Sudha Parasuraman; Bruce D. Cheson

doi:10.1200/JCO.2010.32.1844

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

Nathan Fowler
, Brad S. Kahl
, Peter Lee
, Jeffrey V. Matous
, Amanda F. Cashen
, Samuel A. Jacobs
, Jeffrey Letzer
, Bipinkumar Amin
, Michael E. Williams
, Sonali Smith
, Alfred Saleh
, Peter Rosen
, Hongliang Shi
, Sudha Parasuraman
, Bruce D. Cheson

Lymphoma-Myeloma
University of Wisconsin-Madison
Tower Cancer Research Foundation
Rocky Mountain Cancer Center
Washington University in St. Louis
University of Pittsburgh
Kalamazoo Hematology/Oncology
Legacy Pharma Research
University of Virginia
University of Chicago
Sharp HealthCare
Takeda Pharmaceutical Company
Georgetown University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	29
Issue number	25
DOIs	https://doi.org/10.1200/JCO.2010.32.1844
State	Published - Sep 1 2011
Externally published	Yes

Disciplines

Pharmacology
Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1200/JCO.2010.32.1844License: Unspecified

Cite this

Fowler, N., Kahl, B. S., Lee, P., Matous, J. V., Cashen, A. F., Jacobs, S. A., Letzer, J., Amin, B., Williams, M. E., Smith, S., Saleh, A., Rosen, P., Shi, H., Parasuraman, S., & Cheson, B. D. (2011). Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study. Journal of Clinical Oncology, 29(25). https://doi.org/10.1200/JCO.2010.32.1844

Fowler, N, Kahl, BS, Lee, P, Matous, JV, Cashen, AF, Jacobs, SA, Letzer, J, Amin, B, Williams, ME, Smith, S, Saleh, A, Rosen, P, Shi, H, Parasuraman, S & Cheson, BD 2011, 'Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study', Journal of Clinical Oncology, vol. 29, no. 25. https://doi.org/10.1200/JCO.2010.32.1844

@article{6d526d0acf31449eb9c8dcc830efed9a,

title = "Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study",

author = "Nathan Fowler and Kahl, \{Brad S.\} and Peter Lee and Matous, \{Jeffrey V.\} and Cashen, \{Amanda F.\} and Jacobs, \{Samuel A.\} and Jeffrey Letzer and Bipinkumar Amin and Williams, \{Michael E.\} and Sonali Smith and Alfred Saleh and Peter Rosen and Hongliang Shi and Sudha Parasuraman and Cheson, \{Bruce D.\}",

note = "Purpose The aims of this multicenter study were to evaluate the response rate, progression-free survival, and toxicity of the combination of bortezomib, bendamustine, and rituximab in patients with follicular lymphoma whose disease was relapsed or refractory to prior treatment.",

year = "2011",

month = sep,

day = "1",

doi = "10.1200/JCO.2010.32.1844",

language = "American English",

volume = "29",

journal = "Journal of Clinical Oncology",

number = "25",

}

TY - JOUR

T1 - Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

AU - Fowler, Nathan

AU - Kahl, Brad S.

AU - Lee, Peter

AU - Matous, Jeffrey V.

AU - Cashen, Amanda F.

AU - Jacobs, Samuel A.

AU - Letzer, Jeffrey

AU - Amin, Bipinkumar

AU - Williams, Michael E.

AU - Smith, Sonali

AU - Saleh, Alfred

AU - Rosen, Peter

AU - Shi, Hongliang

AU - Parasuraman, Sudha

AU - Cheson, Bruce D.

N1 - Purpose The aims of this multicenter study were to evaluate the response rate, progression-free survival, and toxicity of the combination of bortezomib, bendamustine, and rituximab in patients with follicular lymphoma whose disease was relapsed or refractory to prior treatment.

PY - 2011/9/1

Y1 - 2011/9/1

UR - https://ascopubs.org/doi/10.1200/JCO.2010.32.1844

U2 - 10.1200/JCO.2010.32.1844

DO - 10.1200/JCO.2010.32.1844

M3 - Article

VL - 29

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -

Bortezomib, Bendamustine, and Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma: The Phase II VERTICAL Study

Disciplines

Access to Document

Other files and links

Cite this